Clinical trials
Recruiting Phase 2 Basal Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Philogen S.p.A. | 2 |
| Fudan University | 1 |
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 1 |
| Mayo Clinic | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| Stamford Pharmaceuticals, Inc. | 1 |
| University Hospital, Lille | 1 |
| University of California, San Diego | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 9 |
| Carcinoma, Transitional Cell | 2 |
| Prostatic Neoplasms | 2 |
| Amyloidosis | 1 |
| Angiomyolipoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Merkel Cell | 1 |
| Carcinoma, Neuroendocrine | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.